<unk>  (Lullan) is an atypical antipsychotic of the azapirone family. It was introduced in Japan by Dainippon Sumitomo Pharma in 2001 for the treatment of schizophrenia and acute cases of bipolar mania.
Perospirone
Tiospirone
Tetherin
Survivin
Neurofilament light polypeptide
Tetraspanin
Alpha-neurotoxin
Precipitin